KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,293,000 | -4.9% | 211,460 | +3.2% | 0.05% | -9.6% |
| Q1 2017 | $16,081,000 | +24.8% | 204,885 | -28.7% | 0.05% | +8.3% |
| Q4 2016 | $12,886,000 | -12.5% | 287,370 | +9.0% | 0.05% | -12.7% |
| Q3 2016 | $14,730,000 | +56.5% | 263,695 | +43.6% | 0.06% | +48.6% |
| Q2 2016 | $9,412,000 | +1248.4% | 183,643 | +1077.2% | 0.04% | +1133.3% |
| Q1 2016 | $698,000 | -27.4% | 15,600 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $961,000 | -63.5% | 15,600 | -67.0% | 0.00% | -66.7% |
| Q3 2015 | $2,634,000 | -58.5% | 47,300 | -45.8% | 0.01% | -53.8% |
| Q2 2015 | $6,353,000 | +32.6% | 87,300 | -8.2% | 0.03% | +30.0% |
| Q1 2015 | $4,791,000 | – | 95,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |